03.02.2019 Issue 161

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Cardiovascular Medical Content Writer with AMCP Dossier and HEOR Knowledge

This individual analyzes and interprets scientific data to update or develop comprehensive, balanced, credible and accurate documents that comply with applicable laws, regulations, guidance's and Client policies and procedures, and are used to appropriately respond to unsolicited inquiries from payers and Health Care Providers.

Senior Principal, Pricing Market Access

Senior Systematic Reviewer

Sr Principal/Principal Health Economics

Senior Market Access Writer, Market Access Communications

Senior Consultant, Market Access Consulting

Associate Scientific Director/Director, Market Access Communications

Provider Contract/Cost of Care Consultant Sr - PS16029

Medical Statistician

Medical Writer / Literature Review Scientist


ICER: Spinraza, Zolgensma Offer 'Substantial Health Benefits'

Opinion: Abandon QALY Metric in Cost-Effectiveness Reviews

Unsealed Testimony Reveals Details About Amazon, Berkshire and J.P. Morgan Health Venture

Column: Tap Pharmacists to Help Wrangle Drug Prices

Industry Spotlight


Conferences Webinars
Patient Assistance and Access Programs 2019
    March 4-6, Baltimore, Maryland

9th Orphan Drugs and Rare Diseases Global Congress 2019 Europe
    March 4-6, London, U.K.

Introduction to Patient-Reported Outcomes
    March 5, York, England

PAP 2019
    March 5-6, Baltimore, Maryland

Patients as Partners U.S.
    March 11-12, Philadelphia, Pennsylvania

Leveraging RWE to Drive Patient Access in the Age of Big Data Analytics
    March 5

Designing Benefits and Payment Models for Innovative High-Investment Medications - Proceedings from the AMCP Partnership Forum
    March 12

What Do Value Assessments Miss? Rethinking Value Using New Health Economics Evidence
    March 13

Conquering the Missing Factor in Hemophilia A: New Evidence and Management Strategies for Patients With and Without Inhibitors
    March 21


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)


Special Thanks to Our Partners:
                   Truven         
              Evidera    HealthCore    University of FL
      Xcenda    OM1    Parexel    Jefferson    Dymaxium    
      Precision Xtract    Pharmerit    eMax Health    Sciformix
       Evidence Partners     ICON